SQTS is caused by gain-of-function potassium channel mutations, predisposing patients to VA, whereas CPVT is associated with dysregulated sarcoplasmic reticulum calcium handling (RyR2 and CASQ2 variants) [92]. This evidence concerns the gene KCNA3 and catecholaminergic polymorphic ventricular tachycardia.